Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study to Asses the Insulin Resistance (IR) and Its Impact on Sustained Virological Response in a Cohort of HCV-infected Patients Treated With Pegasys and Copegus

NCT01200225 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01200225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01200225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study to Asses the Insulin Resistance (IR) and Its Impact on Sustained Virological Response in a Cohort of HCV-infected Patients Treated With Pegasys and Copegus
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
February 28, 2010
Completion date
June 30, 2013
Enrollment
1,155 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, chronic